Scott Rocklage on life science investments

Dr. Scott M. Rocklage is a Ph.D. holder. He acquired his B.S in chemistry from the University of California and his chemistry Ph.D. from Massachusetts Institute of technology. In 2003 Dr. Rocklage joined the 5 AM Ventures as a Venture Partner. In 2004 he became the managing partner. Dr. Rocklage has over 20 years’ experience in healthcare management and his strategic leadership qualities have seen to the approval of three United States new drugs applications by the Food and Drug Administration (Teslascan®, Cubicin®, and Omniscan™) and helped several drug candidates enter into clinical trials. Dr. Rocklage is an inventor and co-inventor of more than 30 United States patents and over 100 peer-reviewed issues.

 

Dr. Rocklage once served as CEO and president of Nycomed Salutar, CEO, and chairman of Cubist Pharmaceuticals, chairman, and CEO of Nycomed interventional. He also held research and development positions in Catalytica and salutar. Dr. Rocklage previously served as the chairman of the board in Novira and Relypsa. And an executive chairman of Semprus, Miikana, and Ilypsa. Currently, he is the chairman board of Cidara, Rennovia, and Kinestral. He also serves on Epirus and Pulmatrix boards.

 

Dr. Rocklage started his life science-based venture business and named it 5 AM ventures because the company formation was thought to be in early stage. He spends most of his days studying life science and other days doing his managerial roles in various companies and works with entrepreneurs like physicians, business executives or scientist to help them shape their ideas onto potential medicine that will help to meet the medical needs that are unmet.

 

As a productive entrepreneur, Dr. Rocklage is well organized regarding calendaring, prioritization and time management. His most significant advice to his fellow entrepreneurs is that “you should not be afraid of taking measured risks for you do better when you have control of your future through entrepreneurship than when working for established companies. He also advises that if you learn you had hired a wrong person, move swiftly and don’t consider goals and performance review as the best way to change the person’s performance nature. According to Dr. Rocklage, web services and software do not have any impact on life science investing.

 

Connect with Dr. Scott Rocklage on LinkedIn.

The Managerial Partner for 5AM, Scott Rocklage

Scott Rocklage is an ambitious individual who is known as the person that made 5AM Ventures elevate. He joined the company as a partner, and within a year, he was promoted. In 2004, he became the managing director and is now a seasoned doctor in healthcare management. Scott Rocklage’s experience is vast and has lasted for more than 30 years of pure excellence. He leads a big group of doctors and plans every move in the organization.

 

As the chairman and CEO of Cubist Pharmaceuticals, he has shown his outstanding leadership. He used to work at Nycomed Salutar at the same level, and he used to occupy the position of Executive Chairperson at Ilypsa while helping Semprus and Miikana.

 

Scott was at the University of California, Berkeley where he acquired a Bachelor of Science Degree in Chemistry. In MIT, he did Ph.D. in chemistry. He has carried out research that was under Richard R Schrock. He was awarded the Nobel Peace Prize in Chemistry in 2005. He has managed to innovate more than 30 patents in the USA. He has reviewed more than 100 publications. His offices are in Boston.

 

Whenever he is in an interview, he is frank and full of confidence and gives views of how life is. He talks with people who want to gain momentum in whatever they do like businesspeople and public officers. Scott always looks for new scientific ideas that will help him take his firm and leadership. Learn more:

 

He is optimistic that the cancer menace will get cure soon. He still enjoys doing research that will result in giving people cure and as a result give people a longer life-span. Scott Rocklage is confident that if every one of us uses their strengths, they will reach their potential. Learn more: https://thebrotalk.com/bro-bio/bro-bio-enigmatic-mysterious-life-dr-scott-rocklage/

 

His challenges when he is working are mostly hiring people who become a liability to the company. Some of the technologies around do not apply primarily in life science, so he does not like investing in them. Scott loves the book, “Good is Great.” Which is a classic showing how business should be handled!